• Ozagrel is used for the treatment of bronchial asthma and cerebral ischemia.

Ozagrel is used as an antiplatelet drug for conditions like cerebral ischemia (reduced blood supply to a part of the brain) and to treat bronchial asthma.

It is a thromboxane A2 inhibitor; thus it blocks platelet aggregation and reduces hypersensitivity of the bronchial muscles.
The drug is currently not available in the United States. 

• Ozagrel is contraindicated if the patient is allergic to the drug.
• It should not be given to children, or pregnant or breastfeeding women.

• Ozagrel is available as 100 and 200 mg tablets, and 40 and 80 mg powder for injection.
• Consult your doctor for the dose appropriate for you.

• Ozagrel is administered either orally or as an injection.

• Caution should be exercised while taking the drug in pregnancy.
• Do not mix the drug with a solution which contains calcium.

•  Gastrointestinal: Gastric discomfort, nausea, abdominal discomfort, vomiting, abnormal liver function tests
•  Skin: Itching of the skin
•  Blood: Bleeding tendency
•  Kidney: Abnormal kidney function, acute kidney failure
•  Others: Dizziness, sleepiness, fever, increased serum potassium levels, allergic reaction

• Use the drug only on the advice of a physician.

• The use of ozagrel with other antiplatelet drugs or anticoagulants can increase the chances of bleeding.

• The drug should be stored at room temperature.